![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SANOFI-AVENTIS PROFITS RISE 53.6 PERCENT ON EXUBERA LICENCE SALE
SANOFI-AVENTIS PROFITS RISE 53.6 PERCENT ON EXUBERA LICENCE SALE
Pharmaceutical group Sanofi-Aventis has reported that first-quarter net profit had surged by 53.6 percent with a big injection from the sale of the patent for diabetes treatment Exubera to US group Pfizer.
TODAYonline (http://www.todayonline.com/articles/116674.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct